المؤلفون: Lim, KHJ, Westphalen, CB, Berghoff, AS, Cardone, C, Connolly, EA, Guven, DC, Kfoury, M, Kocakavuk, E, Mando, P, Mariamidze, E, Matikas, A, Moutafi, M, Oing, C, Pihlak, R, Punie, K, Sanchez-Bayona, R, Sobczuk, P, Starzer, AM, Vuger, AT, Zhu, H, Cruz-Ordinario, MVB, Altuna, SC, Canario, R, Vuylsteke, P, Banerjee, S, de Azambuja, E, Cervantes, A, Lambertini, M, Mateo, J, Amaral, T

المصدر: ESMO open. 8(5):101625

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:154823258

المؤلفون: Englisch C; Medical University of Vienna, Vienna, Austria., Moik F; Medical University of Vienna, Austria., Steiner D; Medical University of Vienna, Vienna, Austria., Starzer AM; Medical University of Graz, Austria., Berghoff AS; Medical University of Vienna, Vienna, Austria., Preusser M; Medical University of Vienna, Vienna, Austria., Pabinger I; Medical University Vienna, Vienna, Austria., Ay C; Medical University of Vienna, Vienna, Austria.

المصدر: Blood [Blood] 2024 Aug 27. Date of Electronic Publication: 2024 Aug 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

المؤلفون: Bartsch R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Furtner J; Department of Radiology, Medical University of Vienna, Vienna, Austria.; Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI), Faculty of Medicine and Dentistry, Danube Private University, Krems, Austria., Marhold M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Bergen ES; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Roider-Schur S; Department of Oncology, St. Joseph's Hospital, Vienna, Austria., Mair MJ; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Starzer AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Forstner H; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Rottenmanner B; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Aretin MB; Hospital Pharmacy, Vienna General Hospital and Medical University of Vienna, Vienna, Austria., Dieckmann K; Department of Radio-Oncology, Medical University of Vienna, Vienna, Austria., Bago-Horvath Z; Department of Pathology, Medical University of Vienna, Vienna, Austria., Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Widhalm G; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria., Ilhan-Mutlu A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Minichsdorfer C; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Fuereder T; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Szekeres T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Oehler L; Research Center for Medical Image Analysis and Artificial Intelligence (MIAAI), Faculty of Medicine and Dentistry, Danube Private University, Krems, Austria., Gruenberger B; Department of Oncology, LKH Wiener Neustadt, Wiener Neustadt, Austria., Pfeiler G; Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria., Singer C; Department of Obstetrics and Gynaecology, Medical University of Vienna, Vienna, Austria., Weltermann A; Department of Medicine 1, Elisabethinen Hospital Linz, Ordensklinikum Linz, Linz, Austria., Berchtold L; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Institute of Medical Statistics, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.

المصدر: Neuro-oncology [Neuro Oncol] 2024 Jul 04. Date of Electronic Publication: 2024 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

المؤلفون: Starzer AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Wolff L; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Popov P; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Kiesewetter B; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Christian Doppler Laboratory for Personalized Immunotherapy, Department of Medicine I, Medical University of Vienna, Vienna, Austria. Electronic address: anna.berghoff@meduniwien.ac.at.

المصدر: Cancer treatment reviews [Cancer Treat Rev] 2024 Apr; Vol. 125, pp. 102718. Date of Electronic Publication: 2024 Mar 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7502030 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1967 (Electronic) Linking ISSN: 03057372 NLM ISO Abbreviation: Cancer Treat Rev Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular* , Liver Neoplasms* , Carcinoma, Renal Cell* , Kidney Neoplasms* , Phenylurea Compounds* , Quinolines*, Humans ; Tyrosine Kinase Inhibitors ; Axitinib ; Prospective Studies

المؤلفون: Ressler JM; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Tomasich E; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Hatziioannou T; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Ringl H; Wiener Gesundheitsverbund, Klinik Donaustadt, Vienna, Austria., Heller G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Silmbrod R; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Gottmann L; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Starzer AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Zila N; Department of Dermatology, Medical University of Vienna, Vienna, Austria.; Division of Biomedical Science, University of Applied Sciences FH Campus Wien, Vienna, Austria., Tschandl P; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Hoeller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Preusser M; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Berghoff AS; Department of Medicine I, Division of Oncology, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. anna.berghoff@meduniwien.ac.at.; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. anna.berghoff@meduniwien.ac.at.

المصدر: Targeted oncology [Target Oncol] 2024 Mar; Vol. 19 (2), pp. 263-275. Date of Electronic Publication: 2024 Feb 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Melanoma*/drug therapy , Melanoma*/genetics , Melanoma*/pathology, Humans ; Male ; Female ; DNA Methylation ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use

المؤلفون: Mair MJ; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Maj-Hes A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Nussbaumer-Pröll A; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Puhr R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Christenheit A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Troch M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Puhr HC; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Starzer AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Steindl A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Eberl S; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Perkmann T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Minichsdorfer C; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Prager GW; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Lamm WW; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Kiesewetter B; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Zeitlinger M; Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria., Raderer M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. markus.raderer@meduniwien.ac.at.

المصدر: Infectious agents and cancer [Infect Agent Cancer] 2023 Feb 12; Vol. 18 (1), pp. 9. Date of Electronic Publication: 2023 Feb 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101276559 Publication Model: Electronic Cited Medium: Print ISSN: 1750-9378 (Print) Linking ISSN: 17509378 NLM ISO Abbreviation: Infect Agent Cancer Subsets: PubMed not MEDLINE

المؤلفون: Bartsch R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Furtner J; Department of Radiology, Medical University of Vienna, Vienna, Austria., Marhold M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Bergen ES; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Roider-Schur S; Department Oncology, St. Joseph's Hospital, Vienna, Austria., Starzer AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Forstner H; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Rottenmanner B; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Dieckmann K; Department of Radio-Oncology, Medical University of Vienna, Vienna, Austria., Bago-Horvath Z; Department of Pathology, Medical University of Vienna, Vienna, Austria., Haslacher H; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Widhalm G; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria., Ilhan-Mutlu A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Minichsdorfer C; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Fuereder T; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Szekeres T; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria., Oehler L; Department Oncology, St. Joseph's Hospital, Vienna, Austria., Gruenberger B; Department of Oncology, LKH Wiener Neustadt, Wiener Neustadt, Austria., Singer CF; Department of Gynaecology, Medical University of Vienna, Vienna, Austria., Weltermann A; Department of Medicine 1, Elisabethinen Hospital Linz, Ordensklinkum Linz, Linz, Austria., Puhr R; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. matthias.preusser@meduniwien.ac.at.

المصدر: Nature medicine [Nat Med] 2022 Sep; Vol. 28 (9), pp. 1840-1847. Date of Electronic Publication: 2022 Aug 08.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/drug therapy , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Immunoconjugates*/adverse effects, Adolescent ; Adult ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Camptothecin/analogs & derivatives ; Female ; Humans ; Prospective Studies ; Receptor, ErbB-2/genetics ; Trastuzumab/adverse effects

المؤلفون: Starzer AM; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Berghoff AS; Division of Oncology, Department of Medicine I, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria.

المصدر: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Apr 30; Vol. 14, pp. 17588359221096219. Date of Electronic Publication: 2022 Apr 30 (Print Publication: 2022).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

المؤلفون: Starzer AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Steindl A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Mair MJ; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Deischinger C; Department of Medicine III, Division of Endocrinology and Metabolism, Medical University of Vienna, Vienna, Austria., Simonovska A; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Widhalm G; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria., Gatterbauer B; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria., Dieckmann K; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Department of Radiotherapy, Medical University of Vienna, Vienna, Austria., Heller G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria. anna.berghoff@meduniwien.ac.at.; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. anna.berghoff@meduniwien.ac.at.

المصدر: British journal of cancer [Br J Cancer] 2022 Apr; Vol. 126 (6), pp. 968.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Starzer AM; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria., Heller G; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria., Tomasich E; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria., Melchardt T; Laboratory for Immunological and Molecular Cancer Research, Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectious Diseases, Rheumatology, Oncologic Center, Paracelsus Medical University Salzburg, Salzburg, Austria., Feldmann K; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria., Hatziioannou T; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria., Traint S; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Minichsdorfer C; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria., Schwarz-Nemec U; Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria., Nackenhorst M; Department of Pathology, Medical University of Vienna, Vienna, Austria., Müllauer L; Department of Pathology, Medical University of Vienna, Vienna, Austria., Preusser M; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria., Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria anna.berghoff@meduniwien.ac.at.; Department of Medicine I, Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria., Fuereder T; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Mar; Vol. 10 (3).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: B7-H1 Antigen*/metabolism , Head and Neck Neoplasms*/drug therapy , Head and Neck Neoplasms*/genetics, Aged ; Aged, 80 and over ; DNA Methylation ; Female ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Male ; Middle Aged ; Programmed Cell Death 1 Receptor ; Squamous Cell Carcinoma of Head and Neck/drug therapy ; Squamous Cell Carcinoma of Head and Neck/genetics ; Tumor Microenvironment